Synthetic non-peptide mimetics of alpha-helices.

Proteins in nature fold into native conformations in which combinations of peripherally projected aliphatic, aromatic and ionic functionalities direct a wide range of properties. Alpha-helices, one of the most common protein secondary structures, serve as important recognition regions on protein surfaces for numerous protein-protein, protein-DNA and protein-RNA interactions. These interactions are characterized by conserved structural features within the alpha-helical domain. Rational design of structural mimetics of these domains with synthetic small molecules has proven an effective means to modulate such protein functions. In this tutorial review we discuss strategies that utilize synthetic small-molecule antagonists to selectively target essential protein-protein interactions involved in certain diseases. We also evaluate some of the protein-protein interactions that have been or are potential targets for alpha-helix mimetics.

[1]  John Sondek,et al.  A crystallographic view of interactions between Dbs and Cdc42: PH domain‐assisted guanine nucleotide exchange , 2002, The EMBO journal.

[2]  S. Sebti,et al.  Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction. , 2005, Angewandte Chemie.

[3]  Michelle Arkin,et al.  Protein-protein interactions and cancer: small molecules going in for the kill. , 2005, Current opinion in chemical biology.

[4]  C. Renner,et al.  Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. , 2001, Biochemistry.

[5]  Yi Zheng,et al.  Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Agarwal,et al.  Design and modular parallel synthesis of a MCR derived alpha-helix mimetic protein-protein interaction inhibitor scaffold. , 2006, Bioorganic & medicinal chemistry letters.

[7]  R. Cerione,et al.  Signaling to the Rho GTPases: networking with the DH domain , 2002, FEBS letters.

[8]  J. Thornton,et al.  Helix geometry in proteins. , 1988, Journal of molecular biology.

[9]  K. Rossman,et al.  Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1 , 2000, Nature.

[10]  H. Willems,et al.  The design of dipeptide helical mimetics: the synthesis, tachykinin receptor affinity and conformational analysis of 1,1,6-trisubstituted indanes. , 1996, Bioorganic & medicinal chemistry.

[11]  Mark Gerstein,et al.  Computational analysis of membrane proteins: genomic occurrence, structure prediction and helix interactions , 2004, Quarterly Reviews of Biophysics.

[12]  J. Blaydes,et al.  The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2 , 1998, Oncogene.

[13]  P. Nieto,et al.  Tachykinins and tachykinin receptors: structure and activity relationships. , 2004, Current medicinal chemistry.

[14]  Maxwell D Cummings,et al.  Substituted 1,4‐Benzodiazepine‐2,5‐diones as α‐Helix Mimetic Antagonists of the HDM2‐p53 Protein–Protein Interaction , 2006, Chemical biology & drug design.

[15]  A. Hamilton,et al.  Strategies for targeting protein-protein interactions with synthetic agents. , 2005, Angewandte Chemie.

[16]  John Calvin Reed.  Double identity for proteins of the Bcl-2 family , 1997, Nature.

[17]  F A Quiocho,et al.  Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. , 1992, Science.

[18]  A. Hamilton,et al.  Diphenylindane-based proteomimetics reproduce the projection of the i, i+3, i+4, and i+7 residues on an alpha-helix. , 2006, Organic letters.

[19]  Xin-Yun Huang,et al.  Structural Basis for Relief of Autoinhibition of the Dbl Homology Domain of Proto-Oncogene Vav by Tyrosine Phosphorylation , 2000, Cell.

[20]  Piet Gros,et al.  Structure of the translocator domain of a bacterial autotransporter , 2004, The EMBO journal.

[21]  S. Cory,et al.  Life-or-death decisions by the Bcl-2 protein family. , 2001, Trends in biochemical sciences.

[22]  Svetlana Litvinchuk,et al.  Blockage of Rigid-rod β-Barrel Pores with Rigid-rod α-Helix Mimics* , 2005 .

[23]  Maxwell D Cummings,et al.  Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. , 2005, Journal of medicinal chemistry.

[24]  S. M. Cowsik,et al.  Three Dimensional Structure of Mammalian Tachykinin Peptide Neurokinin B Bound to Lipid Micelles , 2004, Journal of biomolecular structure & dynamics.

[25]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[26]  Andrew D. Hamilton,et al.  Development of a Potent Bcl-xL Antagonist Based on α-Helix Mimicry , 2002 .

[27]  M. Ikura,et al.  The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. , 2005, Trends in biochemical sciences.

[28]  J. Katzenellenbogen,et al.  Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor α coactivator binding , 2004 .

[29]  D. Engelman,et al.  Sequence motifs, polar interactions and conformational changes in helical membrane proteins. , 2003, Current opinion in structural biology.

[30]  David P. Wilson,et al.  Activation of Smooth Muscle Myosin Light Chain Kinase by Calmodulin , 2002, The Journal of Biological Chemistry.

[31]  M Pastor,et al.  A novel strategy for improving ligand selectivity in receptor-based drug design. , 1995, Journal of medicinal chemistry.

[32]  T. Mitchison,et al.  Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL , 2001, Nature Cell Biology.

[33]  C. Rochette-Egly.  Dynamic Combinatorial Networks in Nuclear Receptor-mediated Transcription* , 2005, Journal of Biological Chemistry.

[34]  J. Winum,et al.  Rigid Push−Pull Oligo(p-Phenylene) Rods: Depolarization of Bilayer Membranes with Negative Membrane Potential , 1999 .

[35]  Shibo Jiang,et al.  Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion. , 2002, Angewandte Chemie.

[36]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[37]  A. Hamilton,et al.  Toward proteomimetics: terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helix. , 2001, Journal of the American Chemical Society.

[38]  Donald J Abraham,et al.  A nonpeptidic sulfonamide inhibits the p53-mdm2 interaction and activates p53-dependent transcription in mdm2-overexpressing cells. , 2004, Journal of medicinal chemistry.

[39]  Andrew D. Hamilton,et al.  Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-xL , 2005 .

[40]  J. King,et al.  Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues , 2001, Protein science : a publication of the Protein Society.

[41]  A. Cochran,et al.  Protein-protein interfaces: mimics and inhibitors. , 2001, Current opinion in chemical biology.

[42]  I. Enyedy,et al.  Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.

[43]  H. Oguri,et al.  Design and synthesis of a trans-fused polycyclic ether skeleton as an α-helix mimetic scaffold , 2005 .

[44]  C. Maggi,et al.  Tachykinins and tachykinin receptors: a growing family. , 2004, Life sciences.

[45]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[46]  Andrew D. Hamilton,et al.  Synthesis of a 2,3‘;6‘,3‘ ‘-Terpyridine Scaffold as an α-Helix Mimetic , 2005 .

[47]  G. Amarasinghe,et al.  Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain. , 2005, Biochemistry.

[48]  H. Willems,et al.  The design of dipeptide helical mimetics, Part I: the synthesis of 1,6-disubstituted indanes , 1995 .

[49]  Sandeep Kumar,et al.  Dissecting α‐helices: Position‐specific analysis of α‐helices in globular proteins , 1998, Proteins.

[50]  S. Sebti,et al.  Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. , 2005, Journal of the American Chemical Society.